摘要
Abstract
Objective:to study the entecavir in patients with decompensated cirrhosis after hepatitis b period of treatment ef ect. Methods:58 patients with decompensated cirrhosis after hepatitis b period were randomly divided into two groups, control group of 29 patients with routine comprehensive treatment, the team in 29 cases in the control group treatment with oral entecavir, based on comparing two groups before and after the treatment of hepatic function index, after treatment, TBil, ALT, propagated and case fatality rate, HBVDNA turn rate. Results:the two groups before treatment there was no statistical y significant dif erence liver result index, (P> 0.05); The team TBil and ALT significantly lower than the control group after treatment, propagated is significantly higher than the control group, (P<0.01). Team was significantly lower than the control group, HBVDNA overcast rate is significantly higher than the control group, (P<0.01). Conclusion:entecavir treatment after hepatitis b cirrhosis of the liver decompensation period has good clinical ef ect, to enhance the antiviral ef ect, control il ness development rapidly, prolong patient life.关键词
恩替卡韦/乙肝后肝硬化/失代偿期/临床效果Key words
Entecavir/Liver cirrhosis after hepatitis/Decompensation period/Clinical ef ect
